Fares Otero, Natalia ElenaLeucht SSeedat S2026-02-272026-02-18Fares N; Leucht S; Seedat S (2026). Assessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.. Lancet Psychiatry, (), S2215-8. DOI: 10.1016/S2215-0366(26)00025-8https://hdl.handle.net/2445/227620Schizophrenia spectrum disorders (SSD) are among the leading global causes of disability, owing to chronic trajectories and high rates of treatment resistance. Antipsychotic medications are generally effective, but in up to a third of individuals with an acute episode, their symptoms show insufficient treatment response, underscoring the need to identify predictors of poor outcomes.application/pdfEnglishhttp://creativecommons.org/licenses/by-nc-nd/4.0/Biological psychiatryCiências biológicas iiEngenharias ivGeneral medicineMedicina iMedicina iiPsychiatryPsychiatry and mental healthSaúde coletivaAssessment of childhood maltreatment in pharmacotherapy trials for schizophrenia.preprint2026-02-26info:eu-repo/semantics/embargoedAccess9492867